Brevan Howard Capital Management’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$397K Buy
+23,342
New +$409K ﹤0.01% 1439
2025
Q4
Sell
-10,800
Closed -$195K 2018
2025
Q3
$195K Sell
10,800
-49,506
-82% -$837K ﹤0.01% 1761
2025
Q2
$956K Buy
+60,306
New +$917K 0.01% 1085
2025
Q1
Sell
-37,644
Closed -$638K 1286
2024
Q4
$638K Sell
37,644
-15,034
-29% -$264K ﹤0.01% 551
2024
Q3
$956K Buy
52,678
+11,100
+27% +$197K 0.01% 469
2024
Q2
$685K Buy
41,578
+3,326
+9% +$50.9K 0.01% 510
2024
Q1
$541K Sell
38,252
-16,350
-30% -$247K ﹤0.01% 434
2023
Q4
$941K Buy
54,602
+34,194
+168% +$522K 0.01% 252
2023
Q3
$312K Buy
+20,408
New +$362K ﹤0.01% 235

Other funds holding HR

Brevan Howard Capital Management's HR Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Healthcare Realty (HR) in Q1 2026: 23,342 shares worth $397K. The stake represents ﹤0.01% of the portfolio and ranks #1439 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in HR as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in HR in Q3 2023 and has held it in 9 quarters since. The position peaked at $956K in Q2 2025. 443 funds tracked by Wall St. Rank hold HR as of Q1 2026.

  • Brevan Howard Capital Management held 23,342 shares of Healthcare Realty worth $397K as of Q1 2026.
  • Healthcare Realty was a new Brevan Howard Capital Management position in Q1 2026.
  • Healthcare Realty made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1439 holding.
  • Brevan Howard Capital Management first reported a position in Healthcare Realty in Q3 2023 and has held it in 9 quarters since.
  • Brevan Howard Capital Management's Healthcare Realty position peaked at $956K in Q2 2025.
  • 443 funds tracked by Wall St. Rank held Healthcare Realty as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.